Nebraska News Desk

Atrial Fibrillation Market Size, Share, Growth And Forecast Report To 2020: Hexa Research

 Breaking News
  • No posts where found

Atrial Fibrillation Market Size, Share, Growth And Forecast Report To 2020: Hexa Research

Hexa Research has announced the addition of “Global Atrial Fibrillation Market Analysis And Segment Forecasts To 2020” Market Research report to their Database

The increased demand for atrial fibrillation and minimally invasive procedures is a direct consequence of rapidly increasing incidences of heart failures, congenital heart diseases and coronary artery diseases all over the world. In young patients, sometimes heart rhythm control cannot be maintained through medication or cardioversion, then radiofrequency ablation can be attempted to control the heart rhythm. The technological advancements in the field of radiofrequency ablation such as the introduction of remotely obtained computed tomography has also increased the growth of the atrial fibrillation market. The risk of atrial fibrillation disease increases with age. As stated by WHO, 8% of people who are over the age of 80 suffer from some kind of atrial fibrillation. The increasing incidences of atrial fibrillation triggering diseases globally, such as obesity, pneumonia, pulmonary embolus, high blood pressure, hyperthyroidism and mitral stenosis is the factor expected to further fuel the atrial fibrillation market over the forecast period.

Full research report on Global Atrial Fibrillation Market with detailed figures and charts available at: 

The global atrial fibrillation market is segmented on the basis of pharmacological procedures and non pharmacological procedures. The pharmacological treatments involve anti coagulant drugs and anti arrhythmic drugs. The non pharmacological procedures are the therapies which does not include drugs for the diagnosis of diseases. The non pharmacological procedure includes diagnosis through procedures such as electric cardioversion, maze surgery and catheter ablation. The surgical catheter ablation dominates the atrial fibrillation market owing to an extremely high success rate in most arrhythmias.

Key points from the study:

  • North America dominated the atrial fibrillation market owing to the huge patient base suffering from heart diseases and the presence of highly elevated procedure volumes which are supported by the presence of refined healthcare infrastructure in this region.
  • Asia Pacific is expected to show lucrative growth over the forecast period owing to the high patient awareness and rapidly increasing healthcare expenditure levels in this region.

Get more information on Global Atrial Fibrillation Market or request for sample of this research report at: 

Key companies analyzed for the research:

  • Boehringer Ingelheim GmbH
  • Johnson & Johnson Ltd.
  • St. Jude Medical Inc.
  • Endoscopic Technologies Inc.
  • Bristol Myers Squibb Corporation
  • Boston Scientific Corporation
  • Cardiofocus Inc.
  • AtriCure Inc.
  • Biosense Webster Inc.
  • Sanofi Aventis

ABOUT Hexa Research

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, visit: 

Related reports by Hexa Research:

Microscopes Market: 

Guidewires Market:

Media Contact
Company Name: Hexa Research
Contact Person: Michelle Thoras
Email: Send Email
Phone: +1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States


February 2018
« Jan